Status:
COMPLETED
Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
Lead Sponsor:
University of Arizona
Collaborating Sponsors:
Centocor, Inc.
Conditions:
Coccidioidomycosis
Rheumatoid Arthritis
Eligibility:
All Genders
Brief Summary
The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.
Detailed Description
Retrospective chart review of all patients with an inflammatory arthritis seen at the University Rheumatology clinic since January 2000.
Eligibility Criteria
Inclusion
- All active patients with an inflammatory arthritis seen at the University of Arizona from January 2000
Exclusion
- None
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
598 Patients enrolled
Trial Details
Trial ID
NCT00796809
Start Date
October 1 2007
End Date
October 1 2008
Last Update
December 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona - Arizona Arthritis Center
Tucson, Arizona, United States, 85724